192 related articles for article (PubMed ID: 36187937)
1. BRCA1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcoma.
Maurer LM; Daley JD; Mukherjee E; Venier RE; Julian CM; Bailey NG; Jacobs MF; Kumar-Sinha C; Raphael H; Periyapatna N; Weiss K; Janeway KA; Mody R; Lucas PC; McAllister-Lucas LM; Bailey KM
Cancer Res Commun; 2022 Apr; 2(4):220-232. PubMed ID: 36187937
[TBL] [Abstract][Full Text] [Related]
2. The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication.
Tarsounas M; Sung P
Nat Rev Mol Cell Biol; 2020 May; 21(5):284-299. PubMed ID: 32094664
[TBL] [Abstract][Full Text] [Related]
3. Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer.
Ozden O; Bishehsari F; Bauer J; Park SH; Jana A; Baik SH; Sporn JC; Staudacher JJ; Yazici C; Krett N; Jung B
Sci Rep; 2016 May; 6():26273. PubMed ID: 27197561
[TBL] [Abstract][Full Text] [Related]
4. Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing's Sarcoma.
Gill SJ; Travers J; Pshenichnaya I; Kogera FA; Barthorpe S; Mironenko T; Richardson L; Benes CH; Stratton MR; McDermott U; Jackson SP; Garnett MJ
PLoS One; 2015; 10(10):e0140988. PubMed ID: 26505995
[TBL] [Abstract][Full Text] [Related]
5. RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination.
Zhu Q; Huang J; Huang H; Li H; Yi P; Kloeber JA; Yuan J; Chen Y; Deng M; Luo K; Gao M; Guo G; Tu X; Yin P; Zhang Y; Su J; Chen J; Lou Z
Nat Commun; 2021 Nov; 12(1):6653. PubMed ID: 34789768
[TBL] [Abstract][Full Text] [Related]
6. Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation.
Li M; Yu X
Cancer Cell; 2013 May; 23(5):693-704. PubMed ID: 23680151
[TBL] [Abstract][Full Text] [Related]
7. Differences in Expression of Key DNA Damage Repair Genes after Epigenetic-Induced BRCAness Dictate Synthetic Lethality with PARP1 Inhibition.
Wiegmans AP; Yap PY; Ward A; Lim YC; Khanna KK
Mol Cancer Ther; 2015 Oct; 14(10):2321-31. PubMed ID: 26294743
[TBL] [Abstract][Full Text] [Related]
8. BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma.
Randall MP; Egolf LE; Vaksman Z; Samanta M; Tsang M; Groff D; Evans JP; Rokita JL; Layeghifard M; Shlien A; Maris JM; Diskin SJ; Bosse KR
J Natl Cancer Inst; 2024 Jan; 116(1):138-148. PubMed ID: 37688570
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) polymerase inhibitors in Ewing sarcoma.
Vormoor B; Curtin NJ
Curr Opin Oncol; 2014 Jul; 26(4):428-33. PubMed ID: 24840521
[TBL] [Abstract][Full Text] [Related]
10. Combining PARP-1 inhibition and radiation in Ewing sarcoma results in lethal DNA damage.
Lee HJ; Yoon C; Schmidt B; Park DJ; Zhang AY; Erkizan HV; Toretsky JA; Kirsch DG; Yoon SS
Mol Cancer Ther; 2013 Nov; 12(11):2591-600. PubMed ID: 23966622
[TBL] [Abstract][Full Text] [Related]
11. Germline missense pathogenic variants in the BRCA1 BRCT domain, p.Gly1706Glu and p.Ala1708Glu, increase cellular sensitivity to PARP inhibitor olaparib by a dominant negative effect.
Vaclová T; Woods NT; Megías D; Gomez-Lopez S; Setién F; García Bueno JM; Macías JA; Barroso A; Urioste M; Esteller M; Monteiro ANA; Benítez J; Osorio A
Hum Mol Genet; 2016 Dec; 25(24):5287-5299. PubMed ID: 27742776
[TBL] [Abstract][Full Text] [Related]
12.
Randall MP; Egolf LE; Vaksman Z; Samanta M; Tsang M; Groff D; Evans JP; Rokita JL; Layeghifard M; Shlien A; Maris JM; Diskin SJ; Bosse KR
bioRxiv; 2023 Feb; ():. PubMed ID: 36778420
[TBL] [Abstract][Full Text] [Related]
13. The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection.
Billing D; Horiguchi M; Wu-Baer F; Taglialatela A; Leuzzi G; Nanez SA; Jiang W; Zha S; Szabolcs M; Lin CS; Ciccia A; Baer R
Mol Cell; 2018 Oct; 72(1):127-139.e8. PubMed ID: 30244837
[TBL] [Abstract][Full Text] [Related]
14. BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites.
Hu Z; Mi S; Zhao T; Peng C; Peng Y; Chen L; Zhu W; Yao Y; Song Q; Li X; Li X; Jia C; Pei H
EMBO J; 2020 Jun; 39(12):e104133. PubMed ID: 32347575
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of BARD1 missense variants in homology-directed repair and damage sensitivity.
Adamovich AI; Banerjee T; Wingo M; Duncan K; Ning J; Martins Rodrigues F; Huang KL; Lee C; Chen F; Ding L; Parvin JD
PLoS Genet; 2019 Mar; 15(3):e1008049. PubMed ID: 30925164
[TBL] [Abstract][Full Text] [Related]
16. A germline BARD1 mutation in a patient with Ewing Sarcoma: Implications for familial testing and counseling.
Venier RE; Maurer LM; Kessler EM; Ranganathan S; McGough RL; Weiss KR; Malek MM; Meade J; Tersak JM; Bailey KM
Pediatr Blood Cancer; 2019 Sep; 66(9):e27824. PubMed ID: 31157509
[No Abstract] [Full Text] [Related]
17. DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex.
Kim HS; Li H; Cevher M; Parmelee A; Fonseca D; Kleiman FE; Lee SB
Cancer Res; 2006 May; 66(9):4561-5. PubMed ID: 16651405
[TBL] [Abstract][Full Text] [Related]
18. Differential requirement for BRCA1-BARD1 E3 ubiquitin ligase activity in DNA damage repair and meiosis in the Caenorhabditis elegans germ line.
Li Q; Kaur A; Okada K; McKenney RJ; Engebrecht J
PLoS Genet; 2023 Jan; 19(1):e1010457. PubMed ID: 36716349
[TBL] [Abstract][Full Text] [Related]
19. BARD1 translocation to mitochondria correlates with Bax oligomerization, loss of mitochondrial membrane potential, and apoptosis.
Tembe V; Henderson BR
J Biol Chem; 2007 Jul; 282(28):20513-22. PubMed ID: 17510055
[TBL] [Abstract][Full Text] [Related]
20. Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patients.
De Brakeleer S; De Grève J; Desmedt C; Joris S; Sotiriou C; Piccart M; Pauwels I; Teugels E
Clin Genet; 2016 Mar; 89(3):336-40. PubMed ID: 26010302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
